Skip to main content
Cube Labs S.p.A. logo

Cube Labs S.p.A. — Investor Relations & Filings

Ticker · CUBE ISIN · IT0005532483 LEI · 815600566D45248BEB28 XMIL Professional, scientific and technical activities
Filings indexed 131 across all filing types
Latest filing 2026-05-12 Proxy Solicitation & In…
Country IT Italy
Listing XMIL CUBE

About Cube Labs S.p.A.

https://cube-labs.com/

Cube Labs S.p.A. is a venture builder specializing in the healthcare technology and life sciences sectors. The company's model focuses on identifying promising academic research and development and transforming it into commercial enterprises. It creates and nurtures startups to bridge the gap between scientific discovery and market-ready healthcare solutions. The firm's investment and development activities cover key areas including pharmaceuticals, biotechnology, medical technology (MedTech), nutraceuticals, and the application of artificial intelligence in R&D. A core part of its mission is to make research, technologies, and tools more accessible, fostering open innovation and collaboration to accelerate the development of new healthcare technologies.

Recent filings

Filing Released Lang Actions
CUBE LABS S.P.A.: PUBBLICATO L’AVVISO DI CONVOCAZIONE DELL’ASSEMBLEA STRAORDINARIA DEGLI AZIONISTI 2026
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a press release announcing and publishing the notice of convocation for an Extraordinary Shareholders’ Meeting, including agenda items, voting procedures, proxy instructions, record dates, and documentation availability. It is not the meeting minutes or results, nor a financial report. It serves as proxy solicitation/information materials requesting votes and providing details for shareholder participation. Therefore, it fits the definition of Proxy Solicitation & Information Statement (Code: PSI).
2026-05-12 Italian
CUBE LABS S.P.A.: IL CONSIGLIO DI AMMINISTRAZIONE DELIBERA DI PROPORRE ALL’ASSEMBLEA DEI SOCI L’ATTRIBUZIONE DI UNA DELEGA AI SENSI DELL’ ART 2443 AD AUMENTARE IL CAPITALE SOCIALE A PAGAMENTO
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory press release by Cube Labs on Euronext Growth Milan announcing that the Board of Directors has resolved to propose to the Extraordinary Shareholders’ Meeting the delegation to increase the company’s share capital under Article 2443 of the Italian Civil Code. It specifically relates to a capital increase proposal via new share issuance. This fits the definition of a Share Issue/Capital Change announcement (Code: SHA).
2026-05-11 Italian
Internal Dealing - Filippo Surace
Regulatory Filings
2026-05-08 Italian
CUBE LABS: DTECH OTTIENE UN BREVETTO NEGLI STATI UNITI PER UN SISTEMA INNOVATIVO A DUE COMPONENTI PER IL TRATTAMENTO DELLE LESIONI CUTANEE
Regulatory Filings Classification · 82% confidence The document is a corporate press release (Regulated Information) announcing that a subsidiary has obtained a US patent. There is no financial result, management change, capital action or other specific filing described. It is not the publication of a scheduled report but a standalone announcement of an operational development. Therefore it falls under the fallback category for general regulatory announcements.
2026-04-21 Italian
Internal Dealing - errata corrige - sostituisce comunicazione 20282-11-2026 del 20 aprile 2026 ore 18:41:56
Director's Dealing Classification · 95% confidence The document is a public disclosure of transactions by a person exercising administrative or management functions (insider dealings), detailing the purchase/sale of the company’s ordinary shares, dates, volumes, and prices. This matches the definition of Director’s Dealing (insider share transactions by directors or senior executives).
2026-04-20 Italian
Internal dealing Keltinvest Srl
Director's Dealing Classification · 95% confidence The document is a notification filed under the EU insider trading regime (Regulation (EU) 596/2014) by Keltinvest Srl (closely associated person) disclosing share transactions in Cube Labs SpA, including ISIN, transaction date, price, volume, and role details. This matches the Director’s Dealing category for insider and related-party share transactions.
2026-04-20 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.